Please login to bookmark Close
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.
Funder to get 30% cut of confidential KPMG class action settlement
Please login to bookmark Close
Litigation funder Litigation Capital Management will snap up 30 percent of a confidential settlement amount that KPMG has fought to keep under wraps in a shareholder class action over a failed $830 million hostile takeover bid of mining firm Discovery Metals.
New laws target insolvent companies that try to dodge worker entitlements
Please login to bookmark Close
The Federal Parliament has passed laws that impose stricter penalties on company directors that try to shirk their duty to pay employee entitlements during an insolvency.
Judge says no to security for costs in unfunded Zoetis horse vaccine class action
Please login to bookmark Close
A judge has refused an application by horse vaccine maker Zoetis for $450,000 as security for costs in an unfunded class action alleging misleading claims by the pharmaceutical company, saying while he had the power to make the order sought, the “principled exercise” of his discretion was to reject the bid.
Live-streaming laws face criticism for being ‘rammed through’ parliament
Please login to bookmark Close
Social media companies will face criminal penalties for failing to promptly remove live-streaming of violent content under a harsh new law that whisked through the Federal Parliament in the wake of the Christchurch terrorist attack, but the world-first law has been slammed by Australia’s peak legal body.
GetSwift class action to get in line behind ASIC case
Please login to bookmark Close
A judge has agreed to postpone a trial against logistics provider GetSwift until next year when a class action and a lawsuit by the Australian Securities and Investments Commission related to the company’s disclosures will be heard consecutively rather than concurrently.
Wrays head wins opposition to MacroGenics immunotherapy patent
Please login to bookmark Close
IP Australia has ordered biotech firm MacroGenics to amend its patent for a type of polypeptide used in treatments for cancer, autoimmune disorders and other diseases after a successful opposition from the chairman of intellectual property boutique Wrays.
Ryan Wilks can’t halt FWC order to reinstate worker fired for ‘inoffensive drunkenness’
Please login to bookmark Close
Electrical and engineering company Ryan Wilks has lost a bid to stay a Fair Work Commission order that an employee sacked for drunken conduct at a work function be reinstated pending a challenge to the ruling, with the workplace umpire doubting the company’s prospects of success on appeal.
Lendlease may face shareholder class action over engineering biz disclosures
Please login to bookmark Close
Maurice Blackburn is investigating a possible shareholder class action against construction company Lendlease over allegedly inadequate disclosures relating to its engineering and services business, which includes the NorthConnex tunnel road project in Sydney.
Former bubble tea franchisee in hot water over alleged underpayments
Please login to bookmark Close
The Fair Work Ombudsman has commenced legal proceedings against a former Chatime franchisee for allegedly underpaying 17 employees over $46,000 at its Sydney CBD store.